EASD 2017: TOSCA.IT: Adding Pioglitazone Is No More Effective Than Sulfonylureas in Preventing Cardiovascular Events in Patients Whose Type 2 Diabetes Is Inadequately Controlled With Metformin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.